Anti-TNF alpha therapy in Inflammatory Bowel Disease - safety profile in elderly patients

被引：0
|
作者：
Bernardes, C. [1 ]
Carvalho, D. [1 ]
Russo, P. [1 ]
Saiote, J. [1 ]
Ramos, J. [1 ]
机构：
[1] Hosp Sto Antonio dos Capuchos, Gastroenterol, Lisbon, Portugal
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P637
引用
收藏
页码：S400 / S400
页数：1
相关论文
共 50 条
  • [41] Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
    Campos, Sara T.
    Portela, Francisco A.
    Tome, Luis
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (05) : 645 - 650
  • [42] Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα Therapy
    Abreu, Candida
    Afonso, Joana
    Dias, Claudia Camila
    Ruas, Rogerio
    Sarmento, Antonio
    Magro, Fernando
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 (10): : 1223 - 1229
  • [43] Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease
    Theodoraki, E.
    Orfanoudaki, E.
    Foteinogiannopoulou, K.
    Andreou, N. P.
    Gazouli, M.
    Koutroubakis, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I354 - I355
  • [44] EXCESSIVE WEIGHT GAIN IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ON ANTI-TNF THERAPY
    Mitchel, Elana
    Huang, Jing
    Zemel, Babette
    Baldassano, Robert N.
    Albenberg, Lindsey
    Denburg, Michelle
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S527 - S528
  • [45] Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease
    De, Tanima
    Zhang, Honghong
    Alarcon, Cristina
    Lec, Bianca
    Avitia, Juan
    Smithberger, Erin
    Chen, Chuyu
    Horvath, Minnie
    Kwan, Sara
    Young, Mary
    Adhikari, Sarbani
    Kwon, John
    Pacheco, Jennifer
    Jarvik, Gail
    Wei, Wei-Qi
    Mentch, Frank
    Hakonarson, Hakon
    Sleiman, Patrick
    Gordon, Adam
    Harley, John
    Linneman, Jim
    Hebbring, Scott
    Parisiadou, Loukia
    Perera, Minoli A.
    [J]. PHARMACOGENETICS AND GENOMICS, 2022, 32 (01): : 1 - 9
  • [46] Anti-TNF Treatment in Inflammatory Bowel Disease
    Yapali, Suna
    Hamzaoglu, Hulya Over
    [J]. ANNALS OF GASTROENTEROLOGY, 2007, 20 (01): : 48 - 53
  • [47] Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease
    Theodoraki, E.
    Orfanoudaki, E.
    Foteinogiannopoulou, K.
    Andreou, N. P.
    Gazouli, M.
    Koutroubakis, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I354 - I355
  • [48] Guide to Discussing the Risks of Immunomodulator and Anti-TNF Therapy with Inflammatory Bowel Disease Patients
    Siegel, Corey A.
    [J]. PRACTICAL GASTROENTEROLOGY, 2007, 31 (11) : 14 - +
  • [49] Anti-TNF therapy is safe and beneficial in Inflammatory Bowel Disease patients with Liver Transplantation
    Shastri, Nikhil
    Venu, Nanda
    Zadvornova, Yelena
    Stein, Daniel
    Perera, Lilani
    Saeian, Kia
    Naik, Amar
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S41 - S41
  • [50] Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease
    Eirini Theodoraki
    Eleni Orfanoudaki
    Kalliopi Foteinogiannopoulou
    Nikolaos-Panagiotis Andreou
    Maria Gazouli
    Ioannis E. Koutroubakis
    [J]. International Journal of Colorectal Disease, 2022, 37 : 639 - 646
12345